Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): Double-blind, randomized, placebo controlled trial

International Braz J Urol

Volumn 28, Issue 5, 2002, Pages 418-425

  Melo, Ézer Amoras ^a   Bertero, Eduardo B ^a   Rios, Luiz A S ^a   Mattos Jr , Demerval ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Phytotherapy; Prostate; Prostatic hyperplasia; Pygeum africanum

Indexed keywords

PLACEBO; PYGEUM AFRICANUM EXTRACT; URTICA DIOICA EXTRACT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; HEADACHE; HUMAN; INTESTINE EXAMINATION; MALE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; PATIENT SELECTION; PHYTOTHERAPY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; URINE FLOW RATE; URODYNAMICS; VERTIGO;

EID: 0036765908     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lowe FC, Fagelman E: Phytotherapy in the treatment of benign prostatic hyperplasia: an update: Urology 1999; 53:671-8.
2. Wagner H, Flachsbarth H, Vogel G: A new antiprostatic principle of stinging nettle (Urtica dioica) roots. Phytomedicine 1994; 1:213-24.
3. +, K-ATPase of the benign prostatic hyperplasia. Planta. Med. 1994; 60:30-3.
4. Hryb DJ, Khan MS, Romas NA, Rosner W: The effects of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Med. 1995; 61:31-2.
5. Lowe FC, Fagelman E: Phytotherapy in the treatment of benign prostatic hyperplasia: an update. Urology 1999; 53:671-8.
6. Levin RM, Riffaud JP, Bellamy F, Rohrmann D, Krasnopolsky L, Haugaard N, et al.: Effects of Tadenan® pretreatment on bladder physiology and biochemistry following partial outlet obstruction. J Urol. 1996; 156:2084-8.
7. Levin RM, Riffaud JP, Bellamy F, Rohrmann D, Habib M, Krasnopolsky L, et al.: Protective effect of Tadenan® on bladder function secondary to partial outlet obstruction. J Urol. 1996; 155:1466-70.
8. Melo EA, Mattos Jr. D, Rios LAS: A double-blind, randomized, placebo-controlled study, to assess the efficacy of alfuzosin in the treatment of patients with benign prostatic hyperplasia. Braz J Urol. 2002; 28:25-32.
9. Astin JA: Why patients use alternative medicine: result of a national study. JAMA. 1998; 279:1548-53.
10. Bartlet A, Albrecht J, Aubert A, Fischer M, Grof F, Grothuesmann HG, et al.: Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study. Wien Klin Wochenschr. 1990; 102:667-73.
11. Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, et al.: Efficacy and acceptability of Tadenan® (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multi-culture trial in Central Europe. Curr Med Res Opin. 1998; 14:127-39.
12. Chatelain C, Autet W, Brackman F: Comparison of once daily and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open-label extension. Urology 1999; 54:473-8.
13. Hansen BJ, Meyhoff HH, Nordling J, Mensink HJ, Mogensen P, Larsen EH: Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol. 1996; 30:373-7.
14. Engelmann U, Boos G, Kres H: Therapie der benignen Prostathyperplasie mit Bazoton Liquidum. Urologe B. 1996; 36:287-91.
15. Andro MC, Riffaud JP: Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 years of published experience. Cur Ther Res. 1995; 56:796-817.
16. Denis LJ, Connell JMC, Yoshida O, et al: Recommendation of the International Scientific Committee: The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction, in Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, July 2-5, 1997. Health Publication Ltd. 1998; pp. 671-2.
17. Lepor H: The treatment of benign prostatic hyperplasia: A glimpse into the future. Urol Clin North Am. 1995; 22:455-9.